| scholarly article | Q13442814 |
| P50 | author | Sanjeev Kumar Sharma | Q38327480 |
| P2093 | author name string | K Vohra | |
| A Syngle | |||
| L Kaur | |||
| P2860 | cites work | Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis | Q24816784 |
| Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score | Q24817087 | ||
| Novel clinical markers of vascular wall inflammation | Q28190821 | ||
| Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group | Q29616063 | ||
| Increased inflammatory activity parallels increased basal nitric oxide production and blunted response to nitric oxide in vivo in rheumatoid arthritis | Q35552814 | ||
| Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity | Q35553196 | ||
| Atherosclerotic cardiovascular disease in rheumatoid arthritis | Q35553376 | ||
| Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment | Q35582571 | ||
| Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response | Q35993119 | ||
| Rheumatoid arthritis: a disease associated with accelerated atherogenesis | Q36220303 | ||
| Cardiovascular involvement in rheumatoid arthritis | Q36283434 | ||
| The pharmacological treatment of primary aldosteronism | Q36428495 | ||
| Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis. | Q40312662 | ||
| Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy | Q44031292 | ||
| Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis | Q44177928 | ||
| Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis | Q44187483 | ||
| Acute and chronic effects of dinner with alcoholic beverages on nitric oxide metabolites in healthy men. | Q44489024 | ||
| Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis | Q44585210 | ||
| Images in cardiovascular medicine. Avoiding papillary muscle infarction with myocardial contrast echocardiographic guidance of nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy | Q44760382 | ||
| Spironolactone inhibits production of proinflammatory cytokines by human mononuclear cells | Q44798715 | ||
| Endothelial dysfunction | Q45000505 | ||
| Simvastatin improves endothelial function in patients with rheumatoid arthritis | Q45244385 | ||
| Increased arterial stiffness and indication of endothelial dysfunction in long-standing rheumatoid arthritis | Q46812634 | ||
| Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody | Q47368581 | ||
| A Practical Procedure for Achieving a Steady State of NOx Concentration in Plasma: with Special Reference to the NOx Content of Japanese Daily Food | Q51536971 | ||
| Brachial Artery Vasodilator Function and Systemic Inflammation in the Framingham Offspring Study | Q57073132 | ||
| P433 | issue | 1 | |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 15-22 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Scandinavian Journal of Rheumatology | Q15767622 |
| P1476 | title | Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis | |
| P478 | volume | 38 |
| Q30539790 | A pilot study of the effect of spironolactone therapy on exercise capacity and endothelial dysfunction in pulmonary arterial hypertension: study protocol for a randomized controlled trial |
| Q33655500 | Assessment of endothelial function as a marker of cardiovascular risk in patients with rheumatoid arthritis |
| Q42905620 | Differential effect of spironolactone in chronic constriction injury and vincristine-induced neuropathic pain in rats |
| Q83139265 | Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor-alpha blockade |
| Q34072179 | Endothelial dysfunction in chronic inflammatory diseases |
| Q37762754 | Inflammation and therapy for hypertension. |
| Q34328380 | Intrathecal injection of spironolactone attenuates radicular pain by inhibition of spinal microglia activation in a rat model |
| Q48317107 | Levels of NT-proBNP, markers of low-grade inflammation, and endothelial dysfunction during spironolactone treatment in patients with diabetic kidney disease |
| Q47958023 | Nitric Oxide: Link between Inflammation and Endothelial Dysfunction in Rheumatoid Arthritis |
| Q38287403 | Renin-angiotensin system in pain: existing in a double life? |
| Q86930914 | Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis |
| Q55107496 | Spironolactone (an adjuvant therapy) in rheumatoid arthritis: a case control study. |
| Q86415237 | Spironolactone improves endothelial dysfunction in ankylosing spondylitis |
| Q33547329 | The role of endothelial function and its assessment in rheumatoid arthritis. |
| Q36246065 | Treatment with the arginase inhibitor Nw-hydroxy-nor-L-arginine restores endothelial function in rat adjuvant-induced arthritis |
Search more.